Neuromyelitis optica spectrum disorder in patient with systemic lupus erythematosus – our experience
Abstract
Introduction. Neuromyelitis optica spectrum disorder (NMOSD) is a rare demyelinating immune-mediated central nervous system disease. It is extremely rare to occur in patients with systemic lupus erythematosus (SLE), and it represents a diagnostic and therapeutic challenge. Case report. A 38-year-old Caucasian woman with medical history of SLE and new onset of flaccid paraparesis, fecal and urinary incontinence, persistent nausea and vomiting was admitted to our hospital. Based on the clinical presentation, magnetic resonance imaging findings and positive aquaporin 4 (AQP4) antibodies, a NMOSD with coexisting SLE were diagnosed. Pulse-doses of cyclophosphamide and glucocorticoids were efficient in patient treatment. Conclusion. In a patient with SLE and symptoms of longitudinal extensive transverse myelitis and/or optic neuritis and area postrema syndrome, assessment of AQP4 antibodies is neccessary for diagnosing NMOSD. Accurate diagnosis, and timely and long-term administration of immunosuppressive therapy are crucial for favorable outcome of these two coexisting diseases.
References
Jarius S, Wildemann B. The history of neuromyelitis optica. J Neuroinflammation 2013; 10: 85.
Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyeli-tis optica. Nat Clin Pract Neurol 2008; 4(4): 202−14.
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Wein-shenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6(9): 805−15.
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85(2): 177−89.
Iyer A, Elsone L, Appleton R, Jacob A. A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica. Autoimmunity 2014; 47(3): 154−61.
Adawi M, Bisharat B, Bowirrat A. Systemic Lupus Erythemato-sus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature. Clin Med Insights Case Rep 2014; 7: 41−7.
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthri-tis Rheum 1999; 42(4): 599−608.
Theodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatr 2006; 77(3): 290−5.
Wingerchuk DM, Lennon VA, Pittock SJ, Luccinetti CF, Wein-shenker BG. Revised diagnostic criteria for neuromyeliris optica. Neurology 2006; 66(10): 1485−9.
Lavalle C, Pizarro S, Drenkard C, Sánchez-Guerrero J, Alarcón-Segovia D. Transverse myelitis: A manifestation of systemic lu-pus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990; 17(1): 34−7.
Nardone R, Fitzgerald RT, Bailey A, Zuccoli G. Longitudinally extensive transverse myelitis in systemic lupus erythematosus: Case report and review of the literature. Clin Neurol Neuro-surg 2015; 129: 57−61.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Fillipi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292−302.
Ringelstein M, Kleiter I, Ayzenberg I, Borisow N, Paul F, Ruprecht K, et al. Visual evoked potentials in neuromyelitis optica and its spectrum disorders. Mult Scler 2014; 20(5): 617−20.
Takahashi T, Miyzawa I, Misu T, Takano R, Nakashima I, Fujihara K, et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: A herald od acute exacerbations. J Neurol Neurosurg Psychiatry 2008; 79(9): 1075−8.
Zhang B, Zhong Y, Wang Y, Dai Y, Qiu W, Zhang L, et al. Neu-romyelitis optica spectrum disorders without and with au-toimmune diseases. BMC Neurol 2014; 14: 162.
Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008; 65(1): 78−83.
Trebst C, Jaruis S, Berthele A, Paul F, Schippling S, Wildemann B, et al. Update on the diagnossi and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014; 261(1): 1−16.
Sherman E, Han MH. Acute and Chronic Management of Neu-romyelitis Optica Spectrum Disorder. Curr Treat Options Neurol 2015; 17(11): 48.